Q&A: How UW researchers are using AI to speed up drug discovery and development

The newly launched Institute for Innovations in Drug Delivery and Disposition (I2D3) brings together expertise from across the University of Washington, including two MolES faculty leaders: Gaurav Bhardwaj, an associate professor of medicinal chemistry who oversees the Institute’s AI-enabled molecular design: and Marco Pravetoni, a professor of psychiatry and behavioral science in the UW School of Medicine, who leads drug discovery, translation and commercialization efforts.

In this Q&A by UW News, learn how they’re applying artificial intelligence methods to address the challenges associated with drug development, the most failure-prone processes in modern science.